4559ゼリア新薬工業

Print Friendly, PDF & Email

製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開

会社サイト   株価   適時開示   大量保有報告書   有価証券報告書

開示年月日決算期種別連個実予売 上 高営業利益経常利益当期利益配当1Q2Q3Q
2006/05/192006/03年度55,5451,9441,8791,24816080
2006/05/192006/09中間27,500 9006000080
2006/11/212006/09中間25,3837107235370080
2006/05/192007/03年度56,000 2,3001,50016080
2007/05/172007/03年度52,7573,4383,3412,06816080
2007/05/172007/09中間26,5009009005500080
2007/11/202007/09中間24,4649439366620080
2007/05/172008/03年度54,5002,7002,6001,55016080
2008/05/132008/03年度49,7212,5602,4461,63916080
2008/08/072008/061Q11,3522342892200000
2008/05/132008/092Q26,0001,2001,2007000080
2008/11/052008/092Q24,1489669277720080
2009/02/062008/123Q35,7611,0851,0638660080
2008/05/132009/03年度53,0002,9002,8001,70016080
2008/11/052009/03年度51,0002,3002,2001,50016080
2009/02/062009/03年度48,0001,6501,6001,20016080
2009/05/192009/03年度47,6701,3241,3661,20316080
2009/08/072009/061Q11,6021712621770000
2009/05/192009/092Q25,0001,1001,1006500080
2009/08/072009/092Q24,0009009005500080
2009/11/112009/092Q24,2729539685780080
2010/02/052009/123Q37,9681,4111,4377520080
2009/05/192010/03年度53,0002,5002,5001,50016080
2009/08/072010/03年度52,0002,0002,0001,20016080
2009/11/112010/03年度53,0002,0002,0001,20016080
2010/05/172010/03年度50,7451,5841,4671,00116080
2010/08/062010/061Q11,7003524572090000
2010/05/172010/092Q26,0001,0001,000600008
~9
0
2010/11/012010/092Q24,7001,8001,8001,100008
~9
0
2010/11/102010/092Q24,7861,8431,8541,1900090
2011/02/042010/123Q37,7592,7452,7091,7320090
2010/05/172011/03年度54,0002,6002,5001,50016
~18
08
~9
0
2010/11/012011/03年度51,0002,9002,8001,80016
~18
08
~9
0
2010/11/102011/03年度51,0002,9002,8001,80018090
2011/02/042011/03年度51,0003,0002,9001,85018090
2011/05/172011/03年度49,4823,3113,1581,84219090
2011/08/052011/061Q13,4601,4081,5791,0300000
2011/05/172011/092Q26,5001,9001,9001,25000100
2011/10/312011/092Q26,5002,6002,6001,70000100
2011/11/082011/092Q26,5872,6882,6111,75000110
2012/02/072011/123Q41,2164,6814,6412,92700110
2011/05/172012/03年度54,5003,5003,5002,250200100
2011/10/312012/03年度54,5003,9003,8002,500220110
2012/02/072012/03年度54,5004,8004,7003,000220110
2012/05/152012/03年度53,1694,5684,4172,861230110
2012/08/092012/061Q12,8598971,0878890000
2012/05/152012/092Q27,0001,5001,4001,60000120
2012/08/082012/092Q27,0001,8001,9002,00000120
2012/11/072012/092Q25,9311,9302,0202,21800130
2013/02/052012/123Q40,2993,4823,6723,27700130
2012/05/152013/03年度56,0004,6004,5003,200240120
2012/11/072013/03年度56,0004,6004,5003,200260130
2013/02/052013/03年度56,0004,6004,5003,500260130
2013/05/162013/03年度53,3174,6114,6763,982270130
2013/08/072013/061Q15,3402,8533,0822,4350000
2013/05/162013/092Q30,0002,9002,9002,25000140
2013/08/072013/092Q30,0003,7003,7002,85000140
2013/11/082013/092Q30,1094,0604,2233,33600140
2014/02/052013/123Q46,7735,9656,0684,57100140
2013/05/162014/03年度60,5005,6005,6004,000280140
2013/08/072014/03年度60,5006,1006,1004,400280140
2013/11/082014/03年度60,5006,4006,4004,700280140
2014/02/052014/03年度61,0006,5006,5004,800290140
2014/05/132014/03年度61,9966,7906,8035,277290140
2014/08/052014/061Q14,7158589431,0480000
2014/05/132014/092Q32,0003,5003,5002,90000150
2014/10/312014/092Q30,1002,3002,2002,10000150
2014/11/102014/092Q30,1362,2792,2402,11500150
2015/02/052014/123Q45,7823,3403,3333,16000150
2014/05/132015/03年度69,0007,4007,4005,800300150
2014/10/312015/03年度64,0005,0005,0004,300300150
2015/04/282015/03年度61,0002,6502,7502,550300150
2015/05/082015/03年度61,0122,6782,7702,557300150
2015/08/052015/061Q14,7251,0275948910000
2015/05/082015/092Q31,0001,5001,00080000150
2015/08/052015/092Q31,0001,6001,1001,10000150
2015/10/282015/092Q30,3002,1001,5501,60000150
2015/11/042015/092Q30,3432,1141,5841,61600150
2016/02/042015/123Q47,0543,7923,7663,33500150
2015/05/082016/03年度65,0004,0003,5003,000300150
2015/10/282016/03年度65,0004,5004,1003,300300150
2016/05/132016/03年度62,4754,5654,4503,513310150
2016/08/042016/061Q16,4881,7201,8321,3280000
2016/05/132016/092Q32,0002,2002,0001,80000160
2016/10/312016/092Q32,3003,1003,0002,00000160
2016/11/042016/092Q32,3133,1483,0832,00600160
2017/02/082016/123Q49,0433,6413,5022,87300160
2016/05/132017/03年度66,0004,8004,6003,600320160
2017/05/122017/03年度64,8494,5414,4383,544320160
2017/08/042017/061Q15,9705976636570000
2017/05/122017/092Q33,0002,3002,3001,60000170
2017/10/202017/092Q32,4002,3502,5002,10000170
2017/11/022017/092Q32,4122,3932,5342,12800170
2018/02/062017/123Q49,6444,5874,8903,95500170
2017/05/122018/03年度68,0005,0005,0003,800340170
2018/02/062018/03年度66,0005,0005,2004,100340170
2018/05/112018/03年度64,5684,8305,0894,157340170
2018/08/032018/061Q15,2591,6321,7412,2440000
2018/05/112018/092Q33,0002,5002,5002,20000170
2018/11/022018/092Q30,4832,0691,9142,28000170
2019/02/052018/123Q47,2153,0612,8192,90000170
2018/05/112019/03年度68,0005,2005,2004,300340170
2018/11/022019/03年度63,0004,3004,0003,600340170
2019/05/102019/03年度61,8313,7373,2953,454340170
2019/08/022019/061Q15,1131,3291,5561,1460000
2019/05/102019/092Q31,0001,8001,8001,40000170
2019/11/012019/092Q30,3171,7381,6281,23000170
2020/02/042019/123Q46,3033,3823,0862,33900170
2019/05/102020/03年度65,0005,0005,0003,800340170
2020/05/212020/03年度60,4264,0943,8792,925340170
2020/05/212020/092Q非開示   00未定0
2020/08/042020/061Q13,3311,0606349740000
2020/08/042020/092Q28,0001,7001,4001,50000170
2020/11/042020/092Q26,8091,3881,0971,21800170
2020/11/112020/092Q26,8091,5981,3071,38800170
2020/05/212021/03年度非開示   未定0未定0
2020/08/042021/03年度61,0004,3003,9003,300340170

2013/10に株式分割(1→1.1)

ゼリア新薬